crizanlizumab
novartis
['crizanlizumab']
71% of people with #sickle cell and priapism had a reduction in priapism on crizanlizumab. i had the honor of caring for some of these patients and seeing their joy when they told me things were getting better. truly practice changing. #ash2022 
She/They ?????? Adult hematologist and sickle cell researcher at Mount Sinai. Cat picture enthusiast.